Sign In

Lior Carmon PhD

Founder and Owner @ Biopharma Investment & Management (BIM) | Competitive Strategy, R&D Management

Lior Carmon is an immunologist and Vaccine expert with extensive experience in the biotech industry. Currently, he is the owner of BIM, a boutique management consulting firm specializing in immunology-related R&D. He founded VaxilBio and developed the ImMucin™ cancer vaccine, which is now in phase 2 clinical trials. Additionally, he co-founded Biokine and played a key role in the development of its lead product for stem cell mobilization. Lior Carmon excels in corporate strategy, financing, investor relations, and company operations, with a focus on R&D, business development, clinical trials, and IP management. He holds numerous granted patents and has authored multiple publications, showcasing his expertise in immunology, Vaccinology, biochemistry, molecular biology, cell biology, and peptide chemistry. Lior's educational background includes a PhD in Tumor Immunology and Immunotherapy, executive studies for CEOs, and an MBA in International Marketing.

Highlights

Aug 29 · linkedin

Choosing the right indication for your therapy is one of the toughest and most crucial steps in drug development. Let's discuss how we can help you make the right decisions. #DrugDevelopment #Biopharma #ClinicalResearch #RegulatoryStrategy #MarketAnalysis #Pharmaceuticals #TherapyDevelopment"

Aug 27 · linkedin

While oncolytic viruses (OVs) offer a novel approach to turning 'cold' tumors into 'hot' ones, they also bring the risk of inadvertently targeting and depleting key immune cells, such as exhausted CD8+ and regulatory CD4+ T cells. Current research suggests that this unintended effect could reduce the overall efficacy of OV therapy, highlighting the importance of a careful strategy. Imyun Pharmaceuticals is focused on addressing these challenges using a novel immune engager linked to pre-existing anti-pathogen immunity.

Related Questions

What are Lior Carmon's main responsibilities at Imyun Pharmaceuticals?
How did Lior Carmon transition from biopharma investment to founding Imyun Pharmaceuticals?
What are some notable projects Lior Carmon has worked on at Imyun Pharmaceuticals?
How has Lior Carmon's experience at the Weizmann Institute of Science influenced his career?
What are Lior Carmon's views on the future of biopharma investment?
Lior Carmon PhD
Lior Carmon PhD, photo 1
Lior Carmon PhD, photo 2
Add to my network

Location

Tel Aviv-Yafo, Tel Aviv District, Israel